{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:54:28Z","timestamp":1790729668142,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016148","name":"Department of Pharmaceutical Chemistry, University of Kansas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016148","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019601","name":"Biomolecular Interaction Centre, University of Canterbury","doi-asserted-by":"publisher","award":["PR40154\/BTIS\/137\/34\/2021"],"award-info":[{"award-number":["PR40154\/BTIS\/137\/34\/2021"]}],"id":[{"id":"10.13039\/100019601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jmgm.2025.109005","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T11:28:00Z","timestamp":1741001280000},"page":"109005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Computational design and structural insights into quinazoline-based lead molecules for targeting PARP10 in cancer therapy"],"prefix":"10.1016","volume":"137","author":[{"given":"Revathi","family":"Gnanavelou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyakanthan","family":"Jeyaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konda Reddy","family":"Girija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2025.109005_bib1","article-title":"Current cancer Epidemiology","volume":"9","author":"Camilla","year":"2019","journal-title":"J. Epidemiol. Glob. Health."},{"key":"10.1016\/j.jmgm.2025.109005_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023, CA A","volume":"73","author":"Siegel","year":"2023","journal-title":"Cancer J Clinicians"},{"key":"10.1016\/j.jmgm.2025.109005_bib3","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1016\/j.ejmech.2010.04.038","article-title":"Synthesis and evaluation of quinazolinone derivatives as inhibitors of NF-\u03baB, AP-1 mediated transcription and eIF-4E mediated translational activation: inhibitors of multi-pathways involve in cancer","volume":"45","author":"Giri","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib4","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jmgm.2025.109005_bib5","year":"2024","journal-title":"International Agency for Research on Cancer"},{"key":"10.1016\/j.jmgm.2025.109005_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022, CA A","volume":"72","author":"Siegel","year":"2022","journal-title":"Cancer J Clinicians"},{"key":"10.1016\/j.jmgm.2025.109005_bib7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(00)04197-0","article-title":"Risk of colorectal cancer after breast cancer","volume":"357","author":"Craig J","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jmgm.2025.109005_bib9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/biom14101269","article-title":"Poly(ADP-Ribose) polymerase (PARP) inhibitors for cancer therapy: advances, challenges, and future directions","volume":"14","author":"Bondar","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmgm.2025.109005_bib10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted therapy for anticancer treatment","volume":"54","author":"Min","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jmgm.2025.109005_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrc2812","article-title":"PARP inhibition: PARP1 and beyond","volume":"10","author":"Rouleau","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jmgm.2025.109005_bib12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.2174\/1389450119666180326122831","article-title":"Nanoparticles in cancer treatment: opportunities and obstacles","volume":"19","author":"Awasthi","year":"2018","journal-title":"CDT"},{"key":"10.1016\/j.jmgm.2025.109005_bib13","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1038\/ncomms5426","article-title":"Family-wide analysis of poly(ADP-ribose) polymerase activity","volume":"5","author":"Vyas","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2025.109005_bib14","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/sj.onc.1208410","article-title":"PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation","volume":"24","author":"Yu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jmgm.2025.109005_bib15","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.3390\/cancers14215210","article-title":"PARP10 mediates mono-ADP-ribosylation of aurora-A regulating G2\/M transition of the cell cycle","volume":"14","author":"Di Paola","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jmgm.2025.109005_bib16","doi-asserted-by":"crossref","first-page":"13627","DOI":"10.1074\/jbc.M114.556340","article-title":"The ADP-ribosyltransferase PARP10\/ARTD10 interacts with proliferating cell nuclear antigen (PCNA) and is required for DNA damage tolerance","volume":"289","author":"Nicolae","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib17","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/ncomms2672","article-title":"Regulation of NF-\u03baB signalling by the mono-ADP-ribosyltransferase ARTD10","volume":"4","author":"Verheugd","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2025.109005_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1478-811X-11-5","article-title":"ARTD10 substrate identification on protein microarrays: regulation of GSK3\u03b2 by mono-ADP-ribosylation","volume":"11","author":"Feijs","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jmgm.2025.109005_bib19","series-title":"Endogenous ADP-Ribosylation","first-page":"167","article-title":"Function and regulation of the mono-ADP-ribosyltransferase ARTD10","author":"Kaufmann","year":"2014"},{"key":"10.1016\/j.jmgm.2025.109005_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2019.100121","article-title":"Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings","volume":"19","author":"Houts","year":"2019","journal-title":"Cancer Treatment and Research Communications"},{"key":"10.1016\/j.jmgm.2025.109005_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2016.08.328","article-title":"In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma","volume":"143","author":"AlHilli","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jmgm.2025.109005_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1042\/BST20130187","article-title":"PARP inhibitors for anticancer therapy","volume":"42","author":"Curtin","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jmgm.2025.109005_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2019.100121","article-title":"Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings","volume":"19","author":"Houts","year":"2019","journal-title":"Cancer Treatment and Research Communications"},{"key":"10.1016\/j.jmgm.2025.109005_bib24","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1021\/jm900052j","article-title":"Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3","volume":"52","author":"Lehti\u00f6","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbrc.2019.01.133","article-title":"Novel pharmacological effects of poly (ADP-ribose) polymerase inhibitor rucaparib on the lactate dehydrogenase pathway","volume":"510","author":"Nonomiya","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jmgm.2025.109005_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173091","article-title":"Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib, prevents acute lung injury associated cognitive deficits potentially through suppression of inflammatory response","volume":"877","author":"Sahu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jmgm.2025.109005_bib27","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1021\/acs.jmedchem.6b00055","article-title":"An update on poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors: opportunities and challenges in cancer therapy","volume":"59","author":"Wang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.48095\/cccg202154","article-title":"Adverse events of PARP inhibitors","volume":"86","author":"Romanov\u00e1","year":"2021","journal-title":"Cesk\u00e1 Gynekol."},{"key":"10.1016\/j.jmgm.2025.109005_bib29","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/S1470-2045(18)30786-1","article-title":"Exploring and comparing adverse events between PARP inhibitors","volume":"20","author":"LaFargue","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jmgm.2025.109005_bib30","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1002\/cam4.5062","article-title":"Hematological toxicities in PARP inhibitors: a real\u2010world study using FDA adverse event reporting system (FAERS) database","volume":"12","author":"Shu","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.jmgm.2025.109005_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100606","article-title":"A review on biological and medicinal impact of heterocyclic compounds","volume":"4","author":"Kabir","year":"2022","journal-title":"Results Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib32","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1039\/C7MD00097A","article-title":"An insight into the therapeutic potential of quinazoline derivatives as anticancer agents","volume":"8","author":"Shagufta","year":"2017","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.jmgm.2025.109005_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/1521-4184(200011)333:11<381::AID-ARDP381>3.0.CO;2-A","article-title":"Synthesis and analgesic activity of some quinazoline analogs of anpirtoline","volume":"333","author":"R\u00e1dl","year":"2000","journal-title":"Arch. Pharm. Pharm. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.101986","article-title":"Recent advances in the synthesis of Quinazoline analogues as Anti-TB agents","volume":"124","author":"Dutta","year":"2020","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jmgm.2025.109005_bib35","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/jm00364a014","article-title":"Synthesis and antihypertensive activity of some new quinazoline derivatives","volume":"26","author":"Honkanen","year":"1983","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131768","article-title":"Design and synthesis of new benzylidene-quinazolinone hybrids as potential anti-diabetic agents: in vitro \u03b1-glucosidase inhibition, and docking studies","volume":"1250","author":"Khalifa","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2025.109005_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116044","article-title":"The natural-based optimization of kojic acid conjugated to different thio-quinazolinones as potential anti-melanogenesis agents with tyrosinase inhibitory activity","volume":"36","author":"Sepehri","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.132283","article-title":"Design, synthesis, biological evaluation, and molecular docking study of thioxo-2,3-dihydroquinazolinone derivative as tyrosinase inhibitors","volume":"1253","author":"Sepehri","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2025.109005_bib39","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41598-022-05736-4","article-title":"Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents","volume":"12","author":"Sohrabi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2025.109005_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.127894","article-title":"Synthesis, antibacterial evaluation, Crystal Structure and Hirshfeld surface analysis of a new 2-Benzylsulfanyl-3-(4-fluoro-phenyl)-6-methyl-3H-quinazolin-4-one","volume":"1208","author":"Geesi","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2025.109005_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129166","article-title":"Synthesis, antibacterial evaluation, crystal structure and molecular interactions analysis of new 6-Bromo-2-chloro-3-butylquinazolin-4(3H)-one","volume":"1225","author":"Ouerghi","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2025.109005_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116330","article-title":"Expedient discovery for novel antifungal leads: 1,3,4-Oxadiazole derivatives bearing a quinazolin-4(3H)-one fragment","volume":"45","author":"Wang","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1039\/C7MD00097A","article-title":"An insight into the therapeutic potential of quinazoline derivatives as anticancer agents","volume":"8","author":"Shagufta","year":"2017","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.jmgm.2025.109005_bib44","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.3390\/molecules28155849","article-title":"Privileged scaffolds for potent and specific inhibitors of mono-ADP-ribosylating PARPs","volume":"28","author":"Nizi","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109005_bib45","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.bmcl.2018.04.056","article-title":"Design, synthesis and evaluation of potent and selective inhibitors of mono-(ADP-ribosyl)transferases PARP10 and PARP14","volume":"28","author":"Holechek","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2025.109005_bib46","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/ph16040534","article-title":"Structure\u2013activity relationship studies based on quinazoline derivatives as EGFR kinase inhibitors (2017\u2013present)","volume":"16","author":"\u0218andor","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jmgm.2025.109005_bib47","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acs.jmedchem.6b00990","article-title":"Structural basis for potency and promiscuity in poly(ADP-ribose) polymerase (PARP) and tankyrase inhibitors","volume":"60","author":"Thorsell","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib48","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2025.109005_bib49","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ct900549r","article-title":"Implementation of the CHARMM force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models","volume":"6","author":"Bjelkmar","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2025.109005_bib50","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/prot.340110305","article-title":"Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations","volume":"11","author":"Ichiye","year":"1991","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2025.109005_bib52","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1021\/acs.jcim.4c01174","article-title":"Conformations of KRAS4B affected by its partner binding and G12C mutation: insights from GaMD trajectory-image transformation-based deep learning","volume":"64","author":"Chen","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109005_bib53","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules29102317","article-title":"Molecular mechanism of phosphorylation-mediated impacts on the conformation dynamics of GTP-bound KRAS probed by GaMD trajectory-based deep learning","volume":"29","author":"Chen","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109005_bib54","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/prot.21344","article-title":"Free energy landscape of a biomolecule in dihedral principal component space: sampling convergence and correspondence between structures and minima","volume":"67","author":"Maisuradze","year":"2007","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2025.109005_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108065","article-title":"Mechanistic insights into the conformational changes and alterations in residual communications due to the mutations in the pncA Gene of Mycobacterium tuberculosis: a computational perspective for effective therapeutic solutions","volume":"110","author":"Jayaraman","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib56","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1080\/07391102.2023.2211674","article-title":"Computational identification and analysis of deleterious non-synonymous single nucleotide polymorphisms (nsSNPs) in the human POR gene: a structural and functional impact","volume":"42","author":"Kumar","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2025.109005_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106266","article-title":"Differential gene expression analysis combined with molecular dynamics simulation study to elucidate the novel potential biomarker involved in pulmonary TB","volume":"182","author":"Panchalingam","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jmgm.2025.109005_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107991","article-title":"Computational insights into potential marine natural products as selective inhibitors of Mycobacterium tuberculosis InhA: a structure-based virtual screening study","volume":"108","author":"Jayaraman","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.jmgm.2025.109005_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110164","article-title":"Harnessing marine natural products to inhibit PAD4 triple mutant: a structure-based virtual screening approach for rheumatoid arthritis therapy","volume":"761","author":"Panchalingam","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jmgm.2025.109005_bib60","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/cancers13061201","article-title":"Bioinformatic analysis of the nicotinamide binding site in poly(ADP-ribose) polymerase family proteins","volume":"13","author":"Manasaryan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jmgm.2025.109005_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116204","article-title":"Virtual screening assisted discovery of novel natural products to inhibit the catalytic mechanism of Mycobacterium tuberculosis InhA","volume":"335","author":"Jayaraman","year":"2021","journal-title":"J. Mol. Liq."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T08:18:24Z","timestamp":1763194704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326325000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":60,"alternative-id":["S1093326325000658"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109005","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational design and structural insights into quinazoline-based lead molecules for targeting PARP10 in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109005"}}